References
- Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission
Dynamics in Wuhan China, of Novel Coronavirus–Infected Pneumonia. N
Engl J Med. 2020;382:1199–1207.
- World Health Organization. Novel coronavirus—China.
https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/.
Accessed January 12, 2020
- Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al.
Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032.
- Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr.
2020;14:247-250.
- Hakmi H, Sohail A, Brathwaite C, Ray B, Abrol S. Cardiac tamponade in
COVID-19 patients: Management and outcomes. J Card Surg.
2020;35:3183-3190.
- Asif T, Kassab K, Iskander F, Alyousef T. Acute Pericarditis and
Cardiac Tamponade in a Patient with COVID-19: A Therapeutic Challenge.
Eur J Case Rep Intern Med. 2020;7:001701.
- Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of
mortality due to COVID-19 based on an analysis of data of 150 patients
from Wuhan, China. Intensive Care Med. 2020;46:846-848.
- Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular
implications of fatal outcomes of patients with coronavirus disease
2019 (COVID-19). JAMA Cardiol 2020; 5: 811-818.
- Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J,
et al. 2015 ESC Guidelines for the diagnosis and management
of pericardial diseases: The Task Force for the Diagnosis and
Management of Pericardial Diseases of the European Society of
Cardiology (ESC)Endorsed by: The European Association for
Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921-2964.